Exact Sciences to participate in September investor conference

News provided by

Sep 01, 2023, 06:00 ET

MADISON, Wis., Sept. 1, 2023 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

Baird Global Healthcare Conference, New York
Fireside chat on Tuesday, September 12, 2023 at 10:50 a.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
[email protected]
608-535-8815

SOURCE Exact Sciences Corporation